Bazelet Health Systems, Inc., a wholly owned subsidiary of Neon Bloom Inc. (OTCMKTS:NBCO), has announced a first-to-market, federally legal cannabis ingredient – PECSA. It is a plant-based, patent-pending, trademarked ingredient for the food, drug, tobacco, and cosmetic industries.
Market Reaction
On Wednesday, NBCO stock ended flat at $0.1610 with more than 600 shares, compared to its average volume of 1.08K shares. The stock moved within a range of $0.1610 – 0.1610 after opening trade at $0.20.
PECSA is short for Plant-based EndoCannabinoid System Activator. It was invented, patented, and trademarked by Bazelet back in 2021. PECSA is produced in forms of butter, oil, flour, sweetener, and seasoning, and contains plant-based, natural compounds beneficial for general well-being and improves symptoms for several conditions. PECSA supports a healthy Endocannabinoid System – it is a part of the human body, which regulates and balances vital bodily functions.
PECSA is a proprietary ingredient made from natural components and botanical extracts from the only US patented cannabis plant – Pan2020. This plant produces high concentrations of cannabigerol (CBG) but zero tetrahydrocannabinol (THC) and zero cannabidiol (CBD). The Pan 2020 plant belongs to a new subspecies of Cannabis Sativa L producing zero percent THC (genetically incapable), all of the time. Thus, it is a federally legal plant.
PECSA is to be supplied to brand name enterprise clients, the food service industry, and Small and Medium Enterprises (SME) that wish to include legal cannabinoid-derived ingredients into their products.
Traders Review
NBCO stock is trading below the 20-Day and 50-Day Moving averages of $0.19 and $0.26 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.34.
